|
Stryker First-Quarter Growth Spurred By Strong Neurotech, Spine Sales
Stryker’s global revenues grew 7.2 percent to $2.2 billion in the 2012 first quarter, bolstered by a 12.4 percent jump in sales of neurotechnology and spine devices.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives